Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
09/29/14 Roche (ROG:VX) Cobimetinib for Melanoma Subscribers Only Subscribers Only     Subscribers Only
09/29/14 Tonix (TNXP) TNX-102 for Fibromyalgia Subscribers Only Subscribers Only     Subscribers Only
09/29/14 Bristol-Myers Squibb (BMY) Nivolumab for Melanoma Subscribers Only Subscribers Only     Subscribers Only
09/29/14 Puma Biotechnology (PBYI) Neratinib for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only     Subscribers Only
09/29/14 Seattle Genetics (SGEN) Adcetris for Hodgkin's Lymphoma Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
09/30/14 Subscribers Only Subscribers Only Trial Announcement - Initiation
09/30/14 Subscribers Only Subscribers Only Trial Announcement - Initiation
09/30/14 Subscribers Only Subscribers Only Regulatory - CHMP (European Panel) Results
09/30/14 Subscribers Only Subscribers Only Trial Announcement - Initiation
09/30/14 Subscribers Only Subscribers Only Trial Announcement - Initiation